CAS NO: | 1809249-37-3 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity, hasEC50s of 3.3 μM, 4.7 μM, 32 μM, 3.7 μM and 9.2 μM forSARS-CoV-2and its variants alpha, beta, gamma and delta, respectively. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19)infectionin vitro[1][2][3]. | ||||||||||||||||
IC50& Target | EC50: 30 nM (murine hepatitis virus, delayed brain tumor cell), 74 nM (SARS-CoV, HAE cell), 74 nM (MERS-CoV, HAE cell)[1] | ||||||||||||||||
体外研究 (In Vitro) | Remdesivir (GS-5734) inhibits murine hepatitis virus (MHV) with an EC50of 30 nM, and blocks SARS-CoV and MERS-CoV in HAE cells with EC50s of both 74 nM in HAE cells after treatment for 24 h[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 602.58 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C27H35N6O8P | ||||||||||||||||
CAS 号 | 1809249-37-3 | ||||||||||||||||
中文名称 | 瑞德西韦 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(165.95 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|